Alternative reading frame protein (ARF; known as p14ARF in humans or p19ARF in mice) is involved in the p53 tumor-suppressor pathway (1) in which ARF inhibits the ubiquitin–protein ligase Mdm2 (or HDM2), and leads to stabilization and elevated levels of p53 (2–5). This evidence concerns the gene CDKN2A and neoplasm.